See more : DEFAMA Deutsche Fachmarkt AG (DEF.DE) Income Statement Analysis – Financial Results
Complete financial analysis of HEXO Corp. (HEXO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HEXO Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Keihanshin Building Co., Ltd. (8818.T) Income Statement Analysis – Financial Results
- RattanIndia Enterprises Limited (RTNINDIA.NS) Income Statement Analysis – Financial Results
- BodyScan Corp. (BDYS) Income Statement Analysis – Financial Results
- HOTLAND Co.,Ltd. (3196.T) Income Statement Analysis – Financial Results
- CareCloud, Inc. (CCLD) Income Statement Analysis – Financial Results
HEXO Corp. (HEXO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hexocorp.com
About HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 191.10M | 123.77M | 80.78M | 47.54M | 4.93M | 4.10M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 266.78M | 74.97M | 138.76M | 20.62M | -1.47M | -2.35M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -75.67M | 48.80M | -57.98M | 26.93M | 6.40M | 6.45M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -39.60% | 39.43% | -71.77% | 56.64% | 129.72% | 157.39% | 0.00% | 0.00% | 0.00% |
| Research & Development | 3.22M | 3.84M | 4.64M | 2.82M | 0.00 | 86.38K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 99.31M | 69.92M | 78.58M | 73.96M | 14.37M | 4.27M | 0.00 | 29.29K | 29.29K |
| Selling & Marketing | 22.93M | 10.35M | 12.47M | 31.19M | 8.34M | 2.99M | 0.00 | 0.00 | 0.00 |
| SG&A | 122.24M | 80.27M | 91.06M | 105.15M | 22.71M | 7.25M | 0.00 | 29.29K | 29.29K |
| Other Expenses | 28.78M | 8.15M | 322.88M | 3.51M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 154.24M | 92.25M | 418.58M | 111.48M | 24.37M | 7.93M | 0.00 | 29.29K | 29.29K |
| Cost & Expenses | 421.01M | 167.22M | 557.34M | 132.10M | 22.90M | 5.58M | 0.00 | 29.29K | 29.29K |
| Interest Income | 1.65M | 1.60M | 1.90M | 5.19M | 2.12M | 92.16K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 20.07M | 32.12M | 10.04M | 469.00K | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 810.10M | 16.73M | 68.25M | 5.85M | 1.66M | 591.65K | 22.82K | 0.00 | 0.00 |
| EBITDA | -257.63M | -26.73M | -476.55M | -78.70M | -14.19M | -1.75M | 0.00 | -29.29K | -29.29K |
| EBITDA Ratio | -134.81% | -21.59% | -589.91% | -165.55% | -287.60% | -42.73% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.07B | -43.45M | -476.55M | -84.56M | -17.97M | -1.48M | 0.00 | -29.29K | -29.29K |
| Operating Income Ratio | -558.72% | -35.11% | -589.91% | -177.86% | -364.14% | -36.21% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -691.53M | -71.71M | -75.96M | -847.00K | -5.38M | -10.93M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.11B | -115.16M | -552.51M | -85.40M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Income Before Tax Ratio | -582.11% | -93.04% | -683.94% | -179.64% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.81M | -397.00K | -6.02M | -3.84M | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.07B | -114.76M | -546.49M | -81.56M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Net Income Ratio | -561.80% | -92.72% | -676.48% | -171.57% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| EPS | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| EPS Diluted | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| Weighted Avg Shares Out | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
| Weighted Avg Shares Out (Dil) | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
HEXO Corp. Announces Receipt of Interim Order in Respect of Arrangement With Tilray Brands, Inc.
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the "Company") is pleased to announce that in connection with its previously announced arrangement agreement with Tilray Brands, Inc. (“Tilray”) for a transaction whereby Tilray has agreed to acquire all...
HEXO Corp. Announces Receipt of Interim Order in Respect of Arrangement With Tilray Brands, Inc.
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the "Company") is pleased to announce that in connection with its previously announced arrangement agreement with Tilray Brands, Inc. (“Tilray”) for a transaction whereby Tilray has agreed to acquire all...
2 Marijuana Stocks To Watch If You Are A Cannabis Investor
2 Top Marijuana Stocks Investors Are Keeping An Eye On In 2023 The post 2 Marijuana Stocks To Watch If You Are A Cannabis Investor appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Penny Stocks To Buy Now? 2 Canadian Cannabis Stocks To Watch
Are These Penny Stocks On Your List For May? The post Top Penny Stocks To Buy Now? 2 Canadian Cannabis Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Canadian Marijuana Stocks Under $2 To Watch In May
Are Canadian Pot Stocks On Your List For May? The post Top Canadian Marijuana Stocks Under $2 To Watch In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
3 Stocks To Buy In The Stock Market On 420
The Best 3 Marijuana Stocks Right Now In The Market The post 3 Stocks To Buy In The Stock Market On 420 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Tilray Acquires HEXO On The Cheap In Surprise Move
Tilray Acquires HEXO On The Cheap In Surprise Move
Is Tilray Stock a Buy or Sell? Here's My Call.
So, it's settled: Canadian cannabis producer Tilray (NASDAQ: TLRY ) plans to acquire rival Hexo (NASDAQ: HEXO ). It's debatable, however, whether this is actually a good idea.
Tilray Brands price target lowered after 3Q earnings and HEXO acquisition announcement
Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have lowered their price target for Tilray Brands after the company announced it is acquiring its strategic partner HEXO for US$56 million in tandem with the release of its fiscal 3Q 2023 results earlier this...
HEXO shares reverse sharply on Tilray acquisition
HEXO Corp shares fell more than 25% on Tuesday after the company revealed it will be acquired by Canadian cannabis market leader Tilray Brands for $56 million in an all-stock deal. After initially spiking on Monday to US$1.64 on rumors...
Source: https://incomestatements.info
Category: Stock Reports